Literature DB >> 7670231

Induction of amphipathic helical peptide structures in RP-HPLC.

A W Purcell1, M I Aguilar, R E Wettenhall, M T Hearn.   

Abstract

The retention behavior of a series of amphipathic peptide multimers based on the amino acid sequence [KSEEQLA]n has been investigated using reversed-phase high performance liquid chromatography (RP-HPLC). Structure-retention parameters which are related to the hydrophobic contact area and affinity of these peptides for the immobilized hydrocarbonaceous ligands were determined over a range of operating temperatures between 5 degrees and 85 degrees C. The influence of ligand hydrophobicity was assessed by comparison of peptide retention behavior using an n-octadecyl (C18)- and an n-butyl (C4)-silica of similar ligand density. The results demonstrated that ligand-mediated conformational effects can stabilize peptide structure depending on the chromatographic residence time and peptide length. In particular, more highly stabilized secondary structures were evident for the longer peptides. In addition, the amphipathic secondary structure of the peptides were more effectively stabilized by the more hydrophobic C18 ligands relative to the shorter C4 ligands. Additional information on the interactive dynamics of these peptide multimers was obtained from analysis of bandwidth dependencies under the different chromatographic conditions. These studies provide further insight into the role which hydrophobic forces can play in the stabilization of peptide structures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7670231

Source DB:  PubMed          Journal:  Pept Res        ISSN: 1040-5704


  8 in total

1.  Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.

Authors:  Yuxin Chen; Colin T Mant; Susan W Farmer; Robert E W Hancock; Michael L Vasil; Robert S Hodges
Journal:  J Biol Chem       Date:  2005-01-27       Impact factor: 5.157

2.  Preparative reversed-phase high-performance liquid chromatography collection efficiency for an antimicrobial peptide on columns of varying diameters (1mm to 9.4mm I.D.).

Authors:  Yuxin Chen; Colin T Mant; Robert S Hodges
Journal:  J Chromatogr A       Date:  2006-12-06       Impact factor: 4.759

3.  Mixed-mode hydrophilic interaction/cation-exchange chromatography: separation of complex mixtures of peptides of varying charge and hydrophobicity.

Authors:  Colin T Mant; Robert S Hodges
Journal:  J Sep Sci       Date:  2008-05       Impact factor: 3.645

4.  Requirements for prediction of peptide retention time in reversed-phase high-performance liquid chromatography: hydrophilicity/hydrophobicity of side-chains at the N- and C-termini of peptides are dramatically affected by the end-groups and location.

Authors:  Brian Tripet; Dziuleta Cepeniene; James M Kovacs; Colin T Mant; Oleg V Krokhin; Robert S Hodges
Journal:  J Chromatogr A       Date:  2006-12-21       Impact factor: 4.759

5.  Conformational analysis of neuropeptide Y-[18-36] analogs in hydrophobic environments.

Authors:  E Lazoura; I Maidonis; E Bayer; M T Hearn; M I Aguilar
Journal:  Biophys J       Date:  1997-01       Impact factor: 4.033

6.  Design of peptide standards with the same composition and minimal sequence variation to monitor performance/selectivity of reversed-phase matrices.

Authors:  Colin T Mant; Robert S Hodges
Journal:  J Chromatogr A       Date:  2012-01-25       Impact factor: 4.759

7.  HPLC analysis and purification of peptides.

Authors:  Colin T Mant; Yuxin Chen; Zhe Yan; Traian V Popa; James M Kovacs; Janine B Mills; Brian P Tripet; Robert S Hodges
Journal:  Methods Mol Biol       Date:  2007

Review 8.  Intrinsic amino acid side-chain hydrophilicity/hydrophobicity coefficients determined by reversed-phase high-performance liquid chromatography of model peptides: comparison with other hydrophilicity/hydrophobicity scales.

Authors:  Colin T Mant; James M Kovacs; Hyun-Min Kim; David D Pollock; Robert S Hodges
Journal:  Biopolymers       Date:  2009       Impact factor: 2.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.